The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

被引：84

作者：

Rio-Machin, Ana ^{[1
]}

Vulliamy, Tom ^{[2
]}

Hug, Nele ^{[3
]}

Walne, Amanda ^{[2
]}

Tawana, Kiran ^{[4
]}

Cardoso, Shirleny ^{[2
]}

Ellison, Alicia ^{[2
]}

Pontikos, Nikolas ^{[2
]}

Wang, Jun ^{[5
]}

Tummala, Hemanth ^{[2
]}

Al Seraihi, Ahad Fahad H. ^{[1
]}

Alnajar, Jenna ^{[2
]}

Bewicke-Copley, Findlay ^{[1
]}

Armes, Hannah ^{[1
]}

Barnett, Michael ^{[6
]}

Bloor, Adrian ^{[7
]}

Bodor, Csaba ^{[8
]}

Bowen, David ^{[9
]}

Fenaux, Pierre ^{[10
]}

Green, Andrew ^{[11
]}

Hallahan, Andrew ^{[12
,13
]}

Hjorth-Hansen, Henrik ^{[14
,15
]}

Hossain, Upal ^{[16
]}

Killick, Sally ^{[17
]}

Lawson, Sarah ^{[18
]}

Layton, Mark ^{[19
]}

Male, Alison M. ^{[20
]}

Marsh, Judith ^{[21
]}

Mehta, Priyanka ^{[22
]}

Mous, Rogier ^{[23
]}

Nomdedeu, Josep F. ^{[24
]}

Owen, Carolyn ^{[25
]}

Pavlu, Jiri ^{[19
]}

Payne, Elspeth M. ^{[26
]}

Protheroe, Rachel E. ^{[22
]}

Preudhomme, Claude ^{[27
,28
]}

Pujol-Moix, Nuria ^{[24
]}

Renneville, Aline ^{[29
]}

Russell, Nigel ^{[30
]}

Saggar, Anand ^{[31
]}

Sciuccati, Gabriela ^{[32
]}

Taussig, David ^{[33
]}

Toze, Cynthia L. ^{[6
]}

Uyttebroeck, Anne ^{[34
]}

Vandenberghe, Peter ^{[34
]}

Schlegelberger, Brigitte ^{[35
]}

Ripperger, Tim ^{[35
]}

Steinemann, Doris ^{[35
]}

Wu, John ^{[36
]}

Mason, Joanne ^{[37
]}

机构：

[1] Queen Mary Univ London, Ctr Haematooncol, Barts Canc Inst, London, England

[2] Queen Mary Univ London, Ctr Genom & Child Hlth, Blizard Inst, London, England

[3] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland

[4] Addenbrookes Hosp, Dept Haematol, Cambridge, England

[5] Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London, England

[6] Univ British Columbia, Fac Med, Dept Med, Leukemia BMT Program British Columbia,Div Hematol, Vancouver, BC, Canada

[7] Christie Hosp, Dept Haematol, Manchester, Lancs, England

[8] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, MTA SE Lendulet Mol Oncohematol Res Grp, Budapest, Hungary

[9] St James Univ Hosp, Dept Haematol, Leeds, W Yorkshire, England

[10] Hop St Louis Univ Paris, Serv Hematol Seniors, Paris, France

[11] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland

[12] Queensland Childrens Hosp, Childrens Hlth Queensland Hosp, South Brisbane, Qld, Australia

[13] Queensland Childrens Hosp, Hlth Serv, South Brisbane, Qld, Australia

[14] Norwegian Univ Sci & Technol NTNU, St Olays Hosp, Dept Hematol, Trondheim, Norway

[15] Norwegian Univ Sci & Technol NTNU, Inst Canc Res & Mol Med IKM, Trondheim, Norway

[16] Barts NHS Trust, Dept Haematol, Whipps Cross Hosp, London, England

[17] Royal Bournemouth Hosp NHS Fdn Trust, Dept Haematol, Bournemouth, Dorset, England

[18] Birmingham Childrens Hosp, Dept Haematol, Birmingham, W Midlands, England

[19] Imperial Coll London, Hammersmith Hosp, Ctr Haematol, London, England

[20] Great Ormond St Hosp Sick Children, Clin Genet Unit, London, England

[21] Kings Coll Hosp London, Haematol Inst, Dept Haematol Med, London, England

[22] Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol Unit, Bristol, Avon, England

[23] Univ Med Ctr Utrecht, UMC Utrecht Canc Ctr, Huispostnummer, Utrecht, Netherlands

[24] Univ Autonoma Barcelona, Lab Hematol, Hosp Santa Creu & St Pau, Barcelona, Spain

[25] Foothills Med Ctr, Div Hematol & Hematol Malignancies, Calgary, AB, Canada

[26] UCL, UCL Canc Inst, Dept Haematol, London, England

[27] Ctr Hosp Reg Univ Lille, Biol & Pathol Ctr, Lab Hematol, Lille, France

[28] Univ Lille, Jean Pierre Aubert Res Ctr, INSERM, Lille, France

[29] Broad Inst Harvard & MIT, Cambridge, MA USA

[30] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England

[31] St George Hosp, Clin Genet, Med Sch, London, England

[32] Hosp Pediat Prof Dr Juan P Garrahan, Serv Hematol & Oncol, Buenos Aires, DF, Argentina

[33] Royal Marsden Hosp, Haemato Oncol Dept, Sutton, Surrey, England

[34] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium

[35] Hannover Med Sch, Inst Humangenet, Hannover, Germany

[36] British Columbia Childrens Hosp, Vancouver, BC, Canada

[37] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham, W Midlands, England

[38] Hamad Bin Khalifa Med City HBKM, Dept Lab Med & Pathol, Qatar Rehabil Inst, Doha, Qatar

[39] Barts NHS Trust, St Bartholomews Hosp, Dept Haematol, London, England

[40] UCL, Genet Inst, London, England

[41] Barts Hlth NHS Trust, London, England

来源：

NATURE COMMUNICATIONS | 2020年 / 11卷 / 01期

基金：

英国医学研究理事会;

关键词：

ACUTE MYELOID-LEUKEMIA; SAMD9L MUTATIONS CAUSE; PLATELET DISORDER; MYELODYSPLASTIC SYNDROME; DYSKERATOSIS-CONGENITA; MECHANISTIC INSIGHTS; RUNX1; MUTATIONS; SELF-RENEWAL; CEBPA; LINE;

D O I：

10.1038/s41467-020-14829-5

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. Here we report a cohort of 86 acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) families with 49 harboring germline variants in 16 previously defined loci (57%). Whole exome sequencing in a further 37 uncharacterized families (43%) allowed us to rationalize 65 new candidate loci, including genes mutated in rare hematological syndromes (ADA, GP6, IL17RA, PRF1 and SEC23B), reported in prior MDS/AML or inherited bone marrow failure series (DNAH9, NAPRT1 and SH2B3) or variants at novel loci (DHX34) that appear specific to inherited forms of myeloid malignancies. Altogether, our series of MDS/AML families offer novel insights into the etiology of myeloid malignancies and provide a framework to prioritize variants for inclusion into routine diagnostics and patient management.

引用

页数：12

共 50 条

[1] The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
Ana Rio-Machin
Tom Vulliamy
Nele Hug
Amanda Walne
Kiran Tawana
Shirleny Cardoso
Alicia Ellison
Nikolas Pontikos
Jun Wang
Hemanth Tummala
Ahad Fahad H. Al Seraihi
Jenna Alnajar
Findlay Bewicke-Copley
Hannah Armes
Michael Barnett
Adrian Bloor
Csaba Bödör
David Bowen
Pierre Fenaux
Andrew Green
Andrew Hallahan
Henrik Hjorth-Hansen
Upal Hossain
Sally Killick
Sarah Lawson
Mark Layton
Alison M. Male
Judith Marsh
Priyanka Mehta
Rogier Mous
Josep F. Nomdedéu
Carolyn Owen
Jiri Pavlu
Elspeth M. Payne
Rachel E. Protheroe
Claude Preudhomme
Nuria Pujol-Moix
Aline Renneville
Nigel Russell
Anand Saggar
Gabriela Sciuccati
David Taussig
Cynthia L. Toze
Anne Uyttebroeck
Peter Vandenberghe
Brigitte Schlegelberger
Tim Ripperger
Doris Steinemann
John Wu
Joanne Mason
Nature Communications, 11
[2] Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants
Ribaudo, Isabella
Arbesman, Michelle
Ni, Ying
Isaacs, James
Kennedy, Lucy Boyce
Ko, Jennifer
Funchain, Pauline
Truong, Thach-Giao
Arbesman, Joshua
PIGMENT CELL & MELANOMA RESEARCH, 2025, 38 (02)
[3] Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients
Tondo-Steele, Katelyn
Milliron, Kara J.
Siedel, Jean H.
Uppal, Shitanshu
Merajver, Sofia D.
Mclean, Karen
GYNECOLOGIC ONCOLOGY REPORTS, 2024, 55
[4] Diverse Landscape of TET2 Variants in MDS and AML
Tallis, Eran
Benton, Christopher B.
Khan, Abir
Assi, Rita
DiNardo, Courtney D.
Hornbaker, Marisa J.
Major, Catherine Kendall
Boddu, Prajwal
Kanagal-Shamanna, Rashmi
Patel, Keyur P.
Daver, Naval G.
Takahashi, Koichi
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Konopleva, Marina Y.
Andreeff, Michael
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
BLOOD, 2018, 132
[5] Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
Przychodzen, Bartlomiej
Makishima, Hideki
Sekeres, Mikkael A.
Balasubramanian, Suresh Kumar
Thota, Swapna
Patel, Bhumika J.
Clemente, Michael
Hirsch, Cassandra
Dienes, Brittney
Maciejewski, Jaroslaw P.
ONCOTARGET, 2018, 9 (02) : 2050 - 2057
[6] Genetic and clinical landscape of breast cancers with germline variants
Toi, Masakazu
Ogawa, Seishi
CANCER SCIENCE, 2023, 114 : 1533 - 1533
[7] Landscape of germline pathogenic variants beyond BRCA in pancreatic cancer patients
Borea, R.
Puccini, A.
Andreotti, V.
Pastorino, L.
Vanni, I.
Catalano, F.
Puglisi, S.
Bruno, W.
Dalmasso, B.
Signori, A.
Fornarini, G.
Ghiorzo, P.
Sciallero, S.
ANNALS OF ONCOLOGY, 2021, 32 : S1093 - S1093
[8] WHOLE EXOME SEQUENCING REVEALS NOVEL CANDIDATE GENES IN FAMILIAL MDS/AML
Rio-Machin, A.
Cardoso, S.
Tawana, K.
Wang, J.
Chelala, C.
Plagnol, V.
Wallis, Y.
Ryan, G.
Ellison, A.
Al Seraihi, A.
Walne, A.
Tummala, H.
Fitzgibbon, J.
Dokal, I.
Vulliamy, T.
HAEMATOLOGICA, 2016, 101 : 205 - 206
[9] Landscape of germline pathogenic variants in cancer susceptibility genes in patients with sarcoma
Rohanizadegan, Mersedeh
Stokes, Samantha
Schneider, Katherine
George, Suzanne
Merriam, Priscilla
Garber, Judy
GENETICS IN MEDICINE, 2022, 24 (03) : S345 - S345
[10] A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants
Earl, Julie
Galindo-Pumarino, Cristina
Encinas, Jessica
Barreto, Emma
Castillo, Maria E.
Pachon, Vanessa
Ferreiro, Reyes
Rodriguez-Garrote, Mercedes
Gonzalez-Martinez, Silvia
Ramon y Cajal, Teresa
Robles Diaz, Luis
Chirivella-Gonzalez, Isabel
Rodriguez, Montse
Martinez de Castro, Eva
Garcia-Seisdedos, David
Munoz, Gloria
Rosa Rosa, Juan Manuel
Marquez, Mirari
Malats, Nuria
Carrato, Alfredo
EBIOMEDICINE, 2020, 53

← 1 2 3 4 5 →